Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8510
-0.0656 (-7.16%)
At close: Aug 20, 2026, 4:00 PM EDT
0.8680
+0.0170 (2.00%)
After-hours: Aug 20, 2026, 4:22 PM EDT
Rani Therapeutics Holdings Employees
As of December 31, 2025, Rani Therapeutics Holdings had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees decreased by 35 or -33.02% compared to the previous year.
Employees
71
Change (1Y)
-35
Growth (1Y)
-33.02%
Revenue / Employee
$68,690
Profits / Employee
-$424,521
Market Cap
118.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 71 | -35 | -33.02% | 69 | 2 |
| Dec 31, 2024 | 106 | -34 | -24.29% | 105 | 1 |
| Dec 31, 2023 | 140 | -23 | -14.11% | 140 | 0 |
| Dec 31, 2022 | 163 | 49 | 42.98% | 163 | 0 |
| Dec 31, 2021 | 114 | 43 | 60.56% | 114 | 0 |
| Sep 30, 2021 | 91 | 20 | 28.17% | 91 | 0 |
| Jun 30, 2021 | 78 | - | - | 78 | 0 |
| Mar 31, 2021 | 71 | - | - | 71 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Seer, Inc. | 124 |
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Vivani Medical | 42 |
| Oncolytics Biotech | 29 |
| Cue Biopharma | 29 |
| Coya Therapeutics | 8 |
RANI News
- 2 days ago - Rani Therapeutics initiated with a Buy at Chardan - TheFly
- 4 days ago - Rani Therapeutics reports Q2 EPS (4c), consensus (5c) - TheFly
- 7 days ago - Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update - GlobeNewsWire
- 7 days ago - Rani Therapeutics Holdings Earnings release: Q2 2026 - Filings
- 7 days ago - Rani Therapeutics Holdings Quarterly report: Q2 2026 - Filings
- 8 days ago - Rani Therapeutics Holdings Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 10 days ago - Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - GlobeNewsWire
- 4 weeks ago - Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire